SuperworthSanara MedTech EV/EBIT SMTI
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2017.
- Today, Oct 23, 2026
- 8.8×
- 9-year median
- 13.0×
- Against its 9-year history
- 30th
- percentile: 0 is its lowest day, 100 its highest
- 9-year range
- 5.1× to 449×
- Peer median
- 14.6×
Sanara MedTech's EV/EBIT is 8.8× as of Oct 23, 2026.
That is below its 9-year median of 13.0×, lower than on 70% of days in the last 9 years.
Over that time it ranged from 5.1× in Apr 2026 to 449× in Sep 2018.
The median for 10 medical instruments and supplies stocks of a similar size is 14.6×.
EV/EBIT over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 8.8× | 5.1× | 9.3× |
| 2025 | 6.9× | 5.7× | 82.2× |
| 2024 | n/m a value too high to mean anything | ||
| 2023 | n/m a value too high to mean anything | ||
| 2022 | n/m a value too high to mean anything | ||
| 2021 | n/m a value too high to mean anything | ||
| 2020 | n/m a value too high to mean anything | ||
| 2019 | n/m a value too high to mean anything | ||
| 2018 | 219× | 16.2× | 449× |
| 2017 | 18.8× | 9.7× | 21.5× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Sanara MedTech's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| SMTISanara MedTech | 8.8× |
| INFUInfuSystem | 22.4× |
| EMBCEmbecta | 6.7× |
| UTMDUtah Medical Products | 6.0× |
| PDEXPro DEX | 16.0× |
| TCMDTactile Systems Technology | 13.3× |
| MDXGMimedx | 51.6× |
| MOVMovado | 11.8× |
| KEQUKewaunee Scientific | 7.2× |
| IRMDIradimed | 37.7× |
| STAAStaar Surgical | 57.7× |
| Peer median | 14.6× |
Where Sanara MedTech ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Sanara MedTech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.